Your session is about to expire
← Back to Search
Surgical Device
Tri Staple for Coronary Artery Disease
N/A
Waitlist Available
Led By Samer G Mattar, MD
Research Sponsored by Medtronic - MITG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post op
Awards & highlights
Summary
The objectives of this clinical trial are to assess in a pilot setting the overall performance and safety of the Endo GIA™ Stapler with Endo GIA™ SULU with Tri-Staple™ Technology when used in a gastric bypass procedure.
Eligible Conditions
- Coronary Artery Disease
- Sleep Apnea
- High Blood Pressure
- Acid Reflux
- Osteoarthritis
- Diabetes
- High Cholesterol
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days post op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post op
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Patients With an Uneventful Creation of a Functional Staple Line
Secondary outcome measures
Incidence of Intra-operative Bleeding Requiring Intervention
Incidence of Serosal Tearing
Length of Hospital Stay
Trial Design
1Treatment groups
Experimental Treatment
Group I: Tri StapleExperimental Treatment1 Intervention
This is a single arm study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tri Staple Technology stapler
2010
N/A
~30
Find a Location
Who is running the clinical trial?
Medtronic - MITGLead Sponsor
255 Previous Clinical Trials
300,879 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
235 Patients Enrolled for Coronary Artery Disease
Samer G Mattar, MDPrincipal InvestigatorIndiana University
Share this study with friends
Copy Link
Messenger